Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01419171 · ClinicalTrials.gov registry record · NA

The OMEGA Clinical Trial

A NA study of Coronary Artery Disease and Atherosclerosis, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
328
Enrollment target
20
Study locations

NCT01419171 is a NA study of Coronary Artery Disease and Atherosclerosis that has completed, run by Boston Scientific Corporation. The registered enrollment target is 328 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01419171, a NA study of Coronary Artery Disease and Atherosclerosis, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
328 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the OMEGA Coronary Stent System for the treatment of subjects with a de novo atherosclerotic coronary artery lesion.

Conditions Studied

Coronary Artery Disease Atherosclerosis

Interventions

  • DEVICE OMEGA™ Monorail Coronary Stent System

Study Locations (20)

Ohio

  • The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital - Cincinnati
  • Ohio State University Medical Center - Columbus
  • The Toledo Hospital - Toledo
  • Mercy St. Vincent Medical Center - Toledo

Arkansas

  • National Park Medical Center - Hot Springs
  • Arkansas Heart Hospital - Little Rock

Florida

  • Florida Hospital - Orlando
  • Sarasota Memorial Hospital - Sarasota

Minnesota

  • St. Mary's Duluth Clinic Regional Heart Center - Duluth
  • Regions Hospital - Saint Paul

California

  • Loma Linda University Medical Center - Loma Linda

Illinois

  • Southern Illinois University-Memorial Medical Center - Springfield

Indiana

  • St. Vincent's Hospital - Indianapolis

Kentucky

  • St. Joseph Hospital - Lexington

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2011-10
Est. Completion 2014-01
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01419171

The ClinicalTrials.gov registry entry for NCT01419171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which OMEGA™ Monorail Coronary Stent System is the first listed.

NCT01419171 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Ohio, Arkansas, Florida.

Frequently Asked Questions

What is clinical trial NCT01419171 about?

NCT01419171 is a clinical study titled "The OMEGA Clinical Trial". The purpose of this study is to evaluate the safety and effectiveness of the OMEGA Coronary Stent System for the treatment of subjects with a de novo atherosclerotic coronary artery lesion.

What is the current status of trial NCT01419171?

This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2011-10. Estimated completion is 2014-01.

What conditions does trial NCT01419171 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Atherosclerosis.

What interventions are being tested in trial NCT01419171?

The interventions under investigation include: OMEGA™ Monorail Coronary Stent System (DEVICE).

Who is sponsoring clinical trial NCT01419171?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01419171 being conducted?

This trial has 20 study locations across Arkansas, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Atherosclerosis

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.